May 5, 2020 8:00 am EDT NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients
Apr 30, 2020 6:00 am EDT NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Apr 29, 2020 5:20 pm EDT NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
Mar 2, 2020 7:00 am EST NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization
Feb 28, 2020 7:00 am EST NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference
Feb 27, 2020 7:08 am EST NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter
